As of Nov 27
| +0.57 / +0.77%|
The 11 analysts offering 12-month price forecasts for DaVita HealthCare Partners Inc have a median target of 82.00, with a high estimate of 95.00 and a low estimate of 74.00. The median estimate represents a +10.33% increase from the last price of 74.32.
The current consensus among 15 polled investment analysts is to Hold stock in DaVita HealthCare Partners Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.